Search

everythinglearnresearchcommunity

for

Search:↓

Superficial cryotherapy is effective and safe for treating alopecia areata, with better results when used early and frequently.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

High-dose corticosteroids and methotrexate had a modest effect on severe childhood alopecia, but side effects and relapse were concerns.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Combining light therapy, acid, and microneedling improves hair regrowth in stubborn hair loss cases.

Alopecia areata may be linked to imbalanced gut bacteria.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

Alopecia areata and androgenetic alopecia affect quality of life similarly.

Low-level laser therapy can stimulate hair growth more effectively than fake devices, but patient satisfaction is similar for both. Results should be taken with caution due to small study sizes and differences between studies. More research is needed.

Alopecia areata causes varying hair loss patterns, affecting hair, nails, and possibly glands, with treatment outcomes depending on disease duration and extent.

The anti-ageing treatment market is growing by exploiting fears of ageing with unproven promises, which could harm public trust and genuine science.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Trichoscopy is useful for diagnosing and monitoring alopecia areata treatment.

Dupilumab for skin problems might reactivate hair loss in some patients.

Platelet-Rich Plasma and stem cell therapy can increase hair count and density, but the best method for preparation and treatment still needs to be determined.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Low vitamin D levels are common in people with Alopecia Areata.

Low-Level Laser Therapy and other light treatments for hair growth lack strong evidence and need more research.

Some people with chronic hair loss may have thyroid autoimmunity.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

Leflunomide and anthralin may effectively treat severe alopecia areata.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

People with alopecia areata may be more likely to have a certain type of hearing loss.

A certain genetic variation in the IL1A gene may lower the risk of a hair loss condition in Chinese people.

HSP90 and lamin A/C are crucial for hair growth and could be targets for treating hair loss.